Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR2 | O43614 | 10/20 | 0.40 |
| ▸ | HCRTR1 | O43613 | 9/20 | 0.40 |
| ▸ | SCD | O00767 | 1/20 | 0.36 |
| ▸ | AURKA | O14965 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.35 |
| ▸ | GPR6 | P46095 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4247674 | 0.90 | HCRTR1 (0.48) | HCRTR2HCRTR1SSTR5 | |
| SCHEMBL4247680 | 0.90 | HCRTR1 (0.48) | HCRTR2HCRTR1SSTR5 | |
| SCHEMBL4245088 | 0.88 | SCD (0.42) | HCRTR2HCRTR1SCDAURKALMNA | |
| SCHEMBL4245082 | 0.88 | SCD (0.42) | HCRTR2HCRTR1SCDAURKALMNA | |
| SCHEMBL8224301 | 0.82 | HCRTR2 (0.47) | HCRTR2HCRTR1SSTR5 | |
| SCHEMBL3661341 | 0.81 | HCRTR2 (0.43) | HCRTR2HCRTR1LMNASSTR5 | |
| SCHEMBL4250853 | 0.81 | HCRTR2 (0.43) | HCRTR2HCRTR1LMNASSTR5 | |
| SCHEMBL8224371 | 0.80 | HCRTR2 (0.47) | HCRTR2HCRTR1SSTR5 | |
| SCHEMBL8218276 | 0.79 | HCRTR2 (0.44) | HCRTR2HCRTR1SSTR5 | |
| SCHEMBL4242950 | 0.76 | SSTR5 (0.42) | HCRTR2HCRTR1SSTR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2234999-A1 | HETEROARYL DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS | F. Hoffmann-La Roche AG (CH) | 2010-10-06 | — | — | EP | disclosed |
| WO-2009080533-A1 | HETEROARYL DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-07-02 | — | — | WO | disclosed |